在PLA2驱动的脂质信号传递驱动ARMS瘤细胞特性
Amogh Gupta1, Bharathi Ramanathan1, Dipanwita Das1
1Department of Physiology, NUS Center for Cancer Research Translation Research Programme, Yong Loo Lin School of Medicine, Healthy Longevity, National University of Singapore, Singapore, 117593, Singapore.
针对儿科大气泡性狂肌肉瘤 (ARMS) 中的光酶A2 (PLA2) 阻碍瘤发起细胞 (TICs) 通过破坏脂质代谢. 这种方法显示出减少ARMS复发和转移的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症新陈代谢 癌症新陈代谢
背景情况:
- 尽管化疗取得了进展,但膜性狂宫肌肉瘤 (ARMS) 的无复发生存率很差.
- 瘤发起细胞 (TICs) 驱动ARMS复发,但它们的特征尚不清楚.
- 脂质新陈代谢越来越多地被认为是癌症干细胞中的作用.
研究的目的:
- 在ARMS中调查TIC的转录和代谢概况.
- 探索脂质代谢在ARMS TIC维护和功能中的作用.
- 在ARMS中评估向脂质代谢的治疗潜力.
主要方法:
- 对ARMS瘤球和附着细胞进行转录和脂质分析.
- RNA测序和质谱学用于识别差异表达的基因和脂质.
- 在体外和体外功能测试以评估脂酶A2 (PLA2) 抑制的影响.
主要成果:
- ARMS TICs表现出高调的脂质新陈代谢,特别是PLA2酶亚型,以及抑制的葡萄糖分解.
- 在TIC中观察到酸衍生脂质的丰富和PLA2活性的增加.
- 抑制PLA2降低了ARMS TIC的自我更新,运动性和瘤生长,这些效应被酸所挽救.
结论:
- 通过PLA2介导的脂质重塑,通过酸信号支持ARMS TIC.
- 抑制PLA2代表了一种有前途的治疗策略,用于准ARMS茎状区.
- 脂质重塑是ARMS TIC中关键的代谢适应,独立于传统的能量通路.
更多相关视频
08:11Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
相关概念视频
Mechanism of Lamellipodia Formation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Second Messengers
